BI BIOLOGICAL INDUSTRIES
LIVE

Serial Number

87452085

Owner

Biological Industries Israel Beit Haemek Ltd.

Attorney

Megan K. Bowen

First Use Date

Apr 28, 2002

Filing Date

May 16, 2017

Add to watchlist:

No watchlists yet
View on USPTO

BI BIOLOGICAL INDUSTRIES Trademark

Serial Number: 87452085 • Registration: 5442098

BI BIOLOGICAL INDUSTRIES is a trademark filed by Biological Industries Israel Beit Haemek Ltd. on May 16, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Biological Industries Israel Beit Haemek Ltd. (8 trademarks)

Haemek 25115 , IL

Entity Type: 11

SARTORIUS BIOLOGICAL INDUSTRIES LTD

Kibbutz Beit Haemek

Entity Type: 98

Trademark Details

Filing Date

May 16, 2017

Registration Date

April 10, 2018

First Use Anywhere

April 28, 2002

First Use in Commerce

April 28, 2002

Published for Opposition

January 23, 2018

Goods & Services

Medical and veterinary preparations and articles, namely, bacterial and bacteriological preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes, Diagnostic agents, preparations and substances for medical purposes; [ Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Bacteriological culture mediums; serums, namely, medicated hair serums; Pharmaceutical preparations, namely, medicated hair serums; Pharmaceutical preparations for human use, namely, human vaccine preparations; Pharmaceutical preparations for medical purposes, namely, diagnostic preparations for medical purposes; ] Pharmaceutical preparations for activating cellular function; Cellular function activating agents for medical purposes; [ Cellulose esters for pharmaceutical purposes; Medicines for intestinal disorders; Pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Live organs and tissues for surgical purpose; ] Stem cells for medical purposes; Clinical medical reagents; Cultures of microorganism for medical use; Medical products to support the growth of stem cells, namely, cytostatics for pharmaceutical purposes; [ Surgical implants grown from stem cells in the nature of surgical implants comprised of living tissues; ] Medical diagnostic reagents; Reargents for blood grouping in the nature of reagents for medical use; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood plasma [ ; Blood substitutes for human use ]

[ Scientific and technological services, namely, scientific research and analysis in the field of medicine; research and development services in connection with medicine; Industrial analysis and research services in the field of medicine; scientific and biological services, namely, biological cloning services; natural science services, namely, consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; medical laboratory services; medical and pharmacological research and development services; biological analysis; biological research; clinical research and medical research, namely, basic and clinical research in the field of respiratory science and medicine; biological development, namely, custom design and development of safe chemical and biological agent simulants for use in air quality measurement; Consultancy relating to pharmaceutical research and development, namely, technical consulting in the field of pharmaceutical studies; Research in the field of stem cells; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Analysis of human serum for medical research; Pharmaceutical drug development services; Provision of information and data relating to medical and veterinary research and development; Testing, authentication and quality control for others in the field of medical and pharmaceutical research; Advisory services relating to material testing, namely, materials testing and analysing; Analysis of human tissues for medical research; Scientific research and development services relating to the isolation and cultivation of human tissues and cells ]

[ Education services, namely, conducting programs and courses in the field of science and medicine; publication services, namely, publishing of journals, books and handbooks; publication of scientific research, namely, publishing and issuing scientific papers in relation to medical technology; Publication of the results of clinical trials for pharmaceutical preparations; Arranging and conducting educational conferences, courses, trainings, seminars in the field of science and medicine ]

Chemicals used in industry and science; [ Mixtures of chemicals and microorganisms for sterilizing compost for use in agriculture; ] Chemical substances, chemical materials and chemical preparations and natural elements all the foregoing being chemicals for use in industry and science; Reagents for scientific or medical research use; Reagents for scientific or medical research use, namely, reagents for use in immunoserology; Diagnostic preparations other than for medical or veterinary purposes; Stem cells for research and scientific purposes; Anti-freezing preparations; Freezing agents for use in freezing biological specimens, namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; Reagents for research purposes, namely, blood grouping reagents other than for medical use; Cell culture media for scientific and research use; Cell culture media for scientific and research use, namely, blood cell culture media for scientific use; [ biological activators for plants; ] Pharmaceuticals, medical and veterinary preparations, namely, biological preparation for use in cell cultures other than for medical or veterinary use

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 24, 2026 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 9, 2024 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 9, 2024 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 5, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 8, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 10, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 10, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Dec 15, 2017 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 8, 2017 ERRR
ASSIGNED TO LIE
Dec 3, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2017 NWOS
NEW APPLICATION ENTERED
May 19, 2017 NWAP